Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fusidic acid hydrophilic cream vs Fucidin for impetigo
2006-002528-41Phase 3Completed
- Sponsor
- Interdos Pharma
- Start
- May 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of fusidic acid in impetigo (2 arms), sponsored by Interdos Pharma. Primary endpoint: Clinical cure at 1 week. Started May 2006; status: completed.
02
Drugs
fusidic acid
03
Conditions
impetigo
Beyond the preview
Go deeper on 2006-002528-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002528-41.